Daniel Tillett
Förmögenhet: 38 M $ per 2026-05-31
Förmögenhet: 38 M $ per 2026-05-31
Dr. Daniel Tillett is a Chief Executive Officer, MD & Director at Racura Oncology Ltd. He is on the Board of Directors at Entropy Neurodynamics Ltd. and Racura Oncology Ltd. Dr. Tillett was previously employed as a Non-Executive Director by Simble Solutions Ltd., an Executive Director & Chief Scientific Officer by Race Oncology Ltd., and a Chief Executive Officer by Nucleics Ltd. He received his undergraduate degree from School of Biotechnology & Biomolecular Sciences and a doctorate degree from School of Biotechnology & Biomolecular Sciences.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
RACURA ONCOLOGY LTD 10,64 % | 2026-05-28 | 20 269 351 ( 10,64 % ) | 38 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| RACURA ONCOLOGY LTD | Verkställande Direktör | 2023-11-22 |
| Företag | Position | Slut |
|---|---|---|
| SIMBLE SOLUTIONS LIMITED | Direktör/Styrelseledamot | 2023-07-03 |
| RACURA ONCOLOGY LTD | Teknisk/Vetenskaplig/F&U Direktör | 2023-03-23 |
Nucleics Ltd. | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Simble Solutions Ltd.
Simble Solutions Ltd. Packaged SoftwareTechnology Services Develops software for enterprises to manage business and resources | Technology Services |
School of Biotechnology & Biomolecular Sciences
School of Biotechnology & Biomolecular Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nucleics Ltd. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån